NNeedham NNVIDIA · NVDA

Needham Reiterates Buy on NVIDIA, $200 PT

Aug 28, 2025· 1 min read· Reproduced verbatim
Rating
Buy
Price target
$200
Previous
—
Implied upside
+10%

Needham analyst Rajvindra Gill reiterated on August 28, 2025, a ‘Buy’ rating and $200 price target on Nvidia.

“NVIDIA delivered a F2Q26 beat, and F3Q26 revenue was in line with no China H20 revenue.

Our key takeaways include:

1) No H20 China sales occurred in F2Q26, and none are assumed in F3Q26 guidance.

If geopolitical issues are resolved in the near-term, management believes it could ship $2-5BN of H20 in F3Q26, with potential upside if additional licenses are granted.;

2) All six of the Rubin chips are in the fab, and we believe Rubin is on track for deployment in C2H26;

3) Blackwell related products, spanning compute and networking, grew +17% Q/Q and Blackwell Ultra generated “tens of billions in revenue”.

Networking grew +46% Q/Q, much stronger than anticipated;

4) Open source models are increasing enterprise AI adoption. Our PT remains $200, based on a ~27x P/E multiple of our new FY28/CY27 NG EPS estimate of $7.40.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.